Instituto Nacional de Psiquiatría Dr. Ramón de la Fuente
15
2
3
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
6.7%
1 terminated/withdrawn out of 15 trials
80.0%
-6.5% vs industry average
7%
1 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (15)
Individual Placement and Support Mexico
Role: lead
Comparison of Two Non-invasive Neuromodulation Techniques as Synergistic Therapy to Cognitive Stimulation in Amnestic Mild Cognitive Impairment (aMCI)
Role: lead
Internet-delivered Cognitive Behavioral Treatment of Depression and Anxiety in Latin American College Students
Role: lead
Effect of HF rTMS on Serum BDNF in Cocaine Use Disorder
Role: lead
Intervention for Reducing Psychiatric Symptoms and Metabolic Variables in Patients With Diabetes Mellitus (DM)
Role: lead
Efficacy Of A Cognitive Behavioral Therapy To Decrease Threat Appraisal In HIV Participants Initiating Antiretroviral
Role: collaborator
Effect of Repeated Transcranial Magnetic Stimulation on Aggressive Impulsive Behavior in Patients With Borderline Personality Disorder in a Social Exclusion Paradigm.
Role: lead
Treatment With Transcranial Magnetic Stimulation for Cocaine Addiction: Clinical Response and Functional Connectivity.
Role: lead
Repetitive Transcranial Magnetic Stimulation in Patients With Alzheimer Disease
Role: lead
Music Therapy for Major Depressive Disorder Residual Symptoms
Role: lead
TMS in Borderline Personality Disorder Patients
Role: lead
BiNational Quit Using Drugs Intervention Trial
Role: collaborator
Clinical Studies on the Therapeutic Effects of Mirtazapine on Drug-craving in Cocaine Addicts.
Role: lead
Pharmacogenetic and Neurofunctional Brain Areas Study in Obese Patients With Binge Eating Disorder
Role: lead
Metabolic Effects of Melatonin in Patients Treated With Second Generation Antipsychotics
Role: lead
All 15 trials loaded